| Descriptor English: | Trastuzumab | ||||||
| Descriptor Spanish: |
Trastuzumab
| ||||||
| Descriptor Portuguese: | Trastuzumab | ||||||
| Descriptor French: | Trastuzumab | ||||||
| Entry term(s): |
Herceptin Trastuzumab beta Trastuzumab qyyp Trastuzumab-qyyp Trazimera beta, Trastuzumab |
||||||
| Tree number(s): |
D12.776.124.486.485.114.224.060.875 D12.776.124.790.651.114.224.060.875 D12.776.377.715.548.114.224.200.875 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000068878 | ||||||
| Scope note: | A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed. |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification DE drug effects EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
| Pharm Action: |
Antineoplastic Agents, Immunological |
||||||
| Registry Number: | P188ANX8CK | ||||||
| Public MeSH Note: | 2016; TRASTUZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 1998-2015 |
||||||
| History Note: | 2016 (1998) |
||||||
| Related: |
Receptor, ErbB-2
MeSH | ||||||
| DeCS ID: | 55980 | ||||||
| Unique ID: | D000068878 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2016/01/01 | ||||||
| Date of Entry: | 2015/07/01 | ||||||
| Revision Date: | 2020/02/06 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
|
Trastuzumab
- Preferred
Herceptin
- Narrower
Trazimera
- Narrower
| Concept UI |
M0291428 |
| Scope note | A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed. |
| Preferred term | Trastuzumab |
| Entry term(s) |
Trastuzumab beta beta, Trastuzumab |
| Concept UI |
M0291429 |
| Preferred term | Herceptin |
| Concept UI |
M000648511 |
| Preferred term | Trazimera |
| Entry term(s) |
Trastuzumab qyyp Trastuzumab-qyyp |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
